DNER and neoplasm: Several small molecule inhibitors of BET proteins (BETi) have been developed as potential anti‐cancer agents, and some are currently undergoing clinical investigation in various tumor types including melanoma (NCT02259114, NCT02369029, NCT01987362, NCT02683395, NCT01587703; Brand et al, 2015).